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The Rhodococcus genus contains species with remarkable ability to tolerate toxic
compounds and to degrade a myriad of substrates. These substrates have to cross
a distinctive cell envelope dominated by mycolic acids anchored in a scaffold of
arabinogalactan covalently attached to the cell wall peptidoglycan, and a cellular membrane
with phospholipids, whose composition in fatty acids can be rapidly altered in response
to environmental conditions. The hydrophobic nature of the cell envelope facilitates the
entrance of hydrophobic molecules but some substrates require active transport systems.
Additionally, toxic compounds may also be extruded by energy spending efflux systems.
In this review, physiological evidences of the use of transport systems by Rhodococcus
strains and genomic studies that corroborate their existence are presented and discussed.
The recently released complete genomes of several Rhodococcus strains will be the basis
for an in silico correlation analysis between the efflux pumps present in the genome and
their role on active transport of substrates. These transport systems will be placed on an
integrative perspective of the impact of this important genus on biotechnology and health,
ranging from bioremediation to antibiotic and biocide resistance.
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INTRODUCTION
THE RHODOCOCCUS GENUS AND ITS TAXONOMY
The genus Rhodococcus comprises aerobic, Gram-positive and
non-motile bacterial cells containing mycolic acids. The complex
phylogenetic structure of this genus and the difficulty in identi-
fying the different species are emphasized by its long taxonomic
history. The name Rhodococcus was initially proposed by Zopf
(1891) for two red bacteria described by Overbeck asMicrococcus
erythromyxa and M. rhodochrous (Overbeck, 1891; Zopf, 1891).
Although the genus Rhodococcus was recognized in the editions
of 1923–1934 of Bergey’s Manual of Determinative Bacteriology,
strains assigned to the rhodochrous complex were suggested as
belonging to several other genera until Tsukamura (1974) revived
the genus Rhodococcus to which six species previously assigned
to the genus Gordona were added. In 1977, a more comprehen-
sive numerical taxonomic study provided a better description
of the Rhodococcus genus and recognized nine species includ-
ing Rhodococcus erythropolis (Goodfellow and Alderson, 1977).
Thirty species were listed in the genus Rhodococcus in the 2nd
edition of Bergey’s Manual of Systematic Bacteriology (Jones and
Goodfellow, 2012).
Based on polyphasic taxonomic data that have been published,
members of the Rhodococcus genus are placed in the mycolic-
acid-forming sub-order Corynebacterineae, family Nocardiaceae,
phylum Actinobacteria. The most important characteristics for
bacterial cells to be placed in this genus are the following:
(i) cell walls containing peptidoglycan consisting of only meso-
diaminopimelic acid as the diamino acid and arabinose and galac-
tose as major sugars; (ii) mycolic acids containing 30–54 carbon
atoms, up to three double bonds and mainly straight-chain sat-
urated, unsaturated and 10-methyl (tuberculostearic)-branched
fatty acids; (iii) a phospholipid profile containing diphos-
phatidylglycerol, phosphatidylethanolamine, phosphatidylinosi-
tol, and phosphatidylinositol mannosides, (iv) dehydrogenated
menaquinones with eight isoprenoid units, and (v) a high con-
tent of G+C in the DNA (Collins et al., 1977; Finnerty, 1992; Bell
et al., 1998; Goodfellow et al., 1998; Nishiuchi et al., 2000; Sutcliffe
et al., 2010; Jones and Goodfellow, 2012).
Several Rhodococcus species are very interesting because of
their metabolic plasticity. Their oxidative metabolism is capa-
ble of using several organic compounds as sole carbon and
energy sources that fostered several industrial and bioreme-
diation applications (Warhurst and Fewson, 1994; Bell et al.,
1998; Oldfield et al., 1998; de Carvalho and da Fonseca, 2005a;
Larkin et al., 2005). The most successful industrial application
of Rhodococcus spp. is probably the production of acrylamide by
the Nitto Chemical Industry, Co. in Japan (Hughes et al., 1998;
Raj et al., 2008; Tao et al., 2009). Rhodococcus strains are able
to degrade and/or convert highly recalcitrant compounds includ-
ing aliphatic-, monoaromatic-, and polyaromatic hydrocarbons,
as well as heterocyclic aromatic compounds making them suit-
able in biocatalytic and bioremediation processes (de Carvalho
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et al., 2007; Pieper and Seeger, 2008; Martínková et al., 2009;
Tyagi et al., 2011). They are also potentially pathogenic with some
strains causing infections in immunosuppressed patients (Topino
et al., 2010; Savini et al., 2012) and in horses (Meijer and Prescott,
2004; Muscatello et al., 2007). Curiously, a gene cluster involved
in cholesterol catabolism in Rhodococcus jostii RHA1 was found
to be conserved in related pathogenic actinomycetes, including
Mycobacterium tuberculosis (van der Geize et al., 2007; Yam et al.,
2011). In fact, genomic analyses have shown thatRhodococcus spp.
may be useful models for mycobacterial studies: ca. 60% of the
genes of M. tuberculosis strain H37Rv are conserved in R. jostii
RHA1 (McLeod et al., 2006; van der Geize et al., 2007).
THE BIOTECHNOLOGICAL ADVANTAGES OF THE RHODOCOCCUS
GENUS
Rhodococci are able to degrade a wide range of hydrophobic nat-
ural compounds and xenobiotics such as short-chain, long-chain,
and halogenated hydrocarbons, and aromatic compounds, like
polycyclic aromatic hydrocarbons, polychlorinated biphenyls and
dibenzothiophenes (DBTs) (Larkin et al., 2005; de Carvalho and
da Fonseca, 2005b). Their well-established cellular resistance and
metabolic ability for the degradation of all these compounds are
related to their genomic properties, with an uncommon pres-
ence of multiple homologs of enzymes participating in major
catabolic pathways and also a remarkable capacity for acquiring
large linear plasmids (van der Geize and Dijkhuizen, 2004; Larkin
et al., 2005). The ability of rhodococci to degrade substituted
hydrocarbons and other chemicals has been used to promote the
bioremediation of such compounds in contaminated environ-
ments (Sikkema et al., 1995; de Carvalho and da Fonseca, 2005a;
de Carvalho et al., 2009; Tyagi et al., 2011). These cells can persist
in the soil under nutrient starvation conditions without affecting
the breakdown-rate of the pollutants, even if more easily degrad-
able carbon sources are present (Warhurst and Fewson, 1994;
Fanget and Foley, 2011). Many of the applications of Rhodococcus
in industrial interesting processes use resting cells resuspended
in medium where the reaction of interest will take place, includ-
ing the biodesulfurization (BDS) of oil (Caro et al., 2007) and
the production of terpenoids (de Carvalho and da Fonseca, 2002,
2003b).
The degradation of hydrophobic pollutants is favored by the
very hydrophobic character of Rhodococcus cells, which is mainly
the result of the presence of aliphatic chains of mycolic acids on
the cell wall. The degradation of hydrophobic pollutants in the
oil/water interfaces is thus very effective because of a remark-
able partitioning of Rhodococcus cells into the oil phase (Neu
et al., 1992; de Carvalho and da Fonseca, 2003a; Martínková et al.,
2009; de Carvalho, 2012). R. erythropolis DCL14 cells are even
able to change their surface net charge to positive values when
growing on long-chain alkanes, which facilitate adhesion to neg-
atively charged surfaces in the environment, such as hexadecane
droplets that have a negative zeta potential in aqueous medium
(de Carvalho et al., 2009).
Another remarkable aspect of rhodococci is their ability to
produce biosurfactants in response to the presence of hydropho-
bic compounds, such as liquid hydrocarbons. The cellular surfac-
tants produced are predominantly glycolipids (Lang and Philp,
1998) and they promote the bioavailability of compounds with
low solubility in water. Biosurfactants also decrease the interfa-
cial tension between organic-aqueous phases, allowing an easier
access of hydrophobic compounds to the cells. The dispersion
of the hydrophobic compounds caused by the surfactants thus
increases the surface area and enhances microbial action (Bell
et al., 1998). Therefore, these bacteria are particularly useful for
the treatment of chemical wastes by bioremediation (Kosaric,
1992; Desai et al., 1994; Karanth et al., 1999; Banat et al., 2010).
Biosurfactants produced by R. erythropolis,R. opacus, andR. ruber
can be successfully applied in the oil industry, e.g., for clean-
ing oil tanks or removing oil from contaminated sands (Ivshina
et al., 1998) and also to enhance oil recovery (Pacheco et al.,
2010). Strain R. erythropolis DCL14 produces a glycolipid bio-
surfactant in the presence of long-chain alkanes resulting in the
reduction of the surface tension of the medium to ca. 23mN/m
(de Carvalho et al., 2009). Adding to this remarkable pleiotropic
metabolic behavior, some Rhodococcus species are psychrotrophic
and/or are able to endure desiccation conditions, which makes
this genus important for bioremediation in cold (Yagafarova and
Skvortsova, 1996; Belousova and Shkidchenko, 2004) and/or arid
climates (Pucci et al., 2000). The adaptation abilities of these cells
have also been used to adapt amesophilic strain to extreme condi-
tions of temperature and pH and to the presence of high amounts
of sodium chloride and copper sulfate (de Carvalho, 2012).
Industrial wastes containing toxic compounds such as chlo-
rinated and aromatic hydrocarbons, nitroaromatics and chlori-
nated polycyclic aromatics can be easily degraded by members
of the Rhodococcus genus (Bell et al., 1998; de Carvalho and
da Fonseca, 2005a; Martínková et al., 2009). Polychlorinated
biphenyls (PCBs), which are persistent organic pollutants, are
efficiently degraded by R. rhodochrous (Boyle et al., 1992) and R.
globerulus (Asturias and Timmis, 1993). Atrazine and s-triazine
containing wastes can be cleaned by R. corallinus (Arnold et al.,
1996) and crude-oil contaminated environments can be effi-
ciently remediated by e.g., R. ruber and R. erythropolis (Bell et al.,
1998; de Carvalho and da Fonseca, 2005a). The strain R. erythro-
polisDCL14 was described as able to degrade a wide range of toxic
compounds, such as n-alkanes and aromatic compounds, fuel
oil, and motor oil, even under saline and extreme conditions (de
Carvalho and da Fonseca, 2005a; de Carvalho et al., 2005, 2007;
de Carvalho, 2012). A variety of other recalcitrant, toxic pollu-
tants have also been shown to be degraded by rhodococci such
as sulphonated azo dyes; pesticides; carbamates (Bell et al., 1998;
de Carvalho and da Fonseca, 2005b); and chlorinated phenols,
which are refractory to degradation and the most hazardous and
persistent pollutants in soil and groundwater (Haggblom et al.,
1989; Briglia et al., 1996; Duque et al., 2012). Rhodococcus spp. are
also capable of catalyzing the BDS of coal and petroleum, being
able to desulfurize refractory organosulfur compounds, which are
difficult to desulfurize by conventional chemical-based technolo-
gies in the oil industry. BDS using Rhodococcus, besides being
a promising biotechnological process, requires less energy while
preventing sulfurous emissions (Kayser et al., 1993; Davoodi-
Dehaghani et al., 2010; Abin-Fuentes et al., 2013).
Several commercially interesting products such as acry-
lamide, acrylic acid and various amides have been produced by
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Rhodococcus species (Yamada and Kobayashi, 1996; Bell et al.,
1998; Bunch, 1998; Abin-Fuentes et al., 2013), as well as dietary
supplements and pharmaceuticals, including vitamins such as
nicotinamide and para-aminobenzoic acid and the antimycobac-
terial agents isonicotinic acid hydrazide (isoniazid) and pyraz-
inamide (Yamada and Kobayashi, 1996). Another interesting
biotechnological usage of Rhodococcus cells takes advantage of
their cholesterol oxidases for the food industry or for the pro-
duction of steroid drugs (Kreit et al., 1994; van der Geize and
Dijkhuizen, 2004; Yam et al., 2011). With high yields and speci-
ficity, these bioconversions using different species of Rhodococcus
have considerable potential for industrial application and have
been well explored since 1990.
There are two species with clear interest for biotechnological
purposes: R. rhodochrous and R. erythropolis. The latter is one
of the most well studied species of Rhodococcus due to its broad
substrate specificity, biotechnological properties, and adaptabil-
ity to extreme conditions (de Carvalho, 2012). These bacteria
tolerate, at relative high concentrations, water-miscible solvents
such as ethanol, butanol, and dimethylformamide (DMF) (de
Carvalho et al., 2004; Yam et al., 2011), and water-immiscible
solvents such as long-chain alkanes, aromatic compounds, and
phthalates, being highly versatile bacteria for bioremediation and
biotransformation processes (de Carvalho and da Fonseca, 2005b;
de Carvalho et al., 2007, 2009; Yam et al., 2011).
THE PATHOLOGICAL TRAITS OF THE RHODOCOCCUS GENUS
Rhodococcus are ubiquitous: rhodococcal strains have been iso-
lated from samples collected in cold Arctic and Antarctic soil
(Whyte et al., 2002), arid sites (Pucci et al., 2000), deep-sea
(Colquhoun et al., 1998), animal, and plant tissues (Goodfellow,
1992; de Carvalho and da Fonseca, 2005b). A few of these species
can cause infections. R. fascians is a phytopathogenic bacterium
that causes fasciation in a wide range of monocotyledonous and
dicotyledonous plants, an infection that causes several malforma-
tions, ranging from deformation of leaves, to witches’ brooms
formation, and leafy galls (Crespi et al., 1992; Vereecke et al.,
2000). Infections caused by R. fascians affect a wide range of crops
and plants, such as peas and tobacco, causing a significant eco-
nomic impact (Bell et al., 1998). Although the bacterial infection
does not affect the lifespan of the infected plants, the ornamental
industry that is based on the plant esthetics is the most affected
industry, with considerable financial losses due to infections by R.
fascians (Depuydt et al., 2008).
R. equi (formerlyCorynebacterium equi) is the etiological agent
of the rhodococcosis, a chronic granulomatous pneumonia caus-
ing lung abscesses that occurs in horses and other animals, with
high incidence in foals under 6 months old (Prescott, 1991; Bell
et al., 1998). Although R. equi infections may occur in adult
horses, foals are the only animals in which infection is common.
The symptoms include fever and general respiratory distress.
Usually, chronic pus-filled lung abscesses develop and untreated
lesions can progress and cause death by asphyxiation (Lavoie
et al., 1994). The infection can disseminate from the lungs to the
gut lining (causing diarrhea), to other organs and to the joints.
Vertebral osteomyelitis can also occur (Prescott, 1991; Bell et al.,
1998). Because the bacteria are widespread in soil the herbivore
dung provides a good culture medium for the bacterium to grow,
keeping foals in crowded conditions may increase the likelihood
of exposure to an infective dose of R. equi (McNeil and Brown,
1994). Although foals are the most affected mammals by this
bacterium, the tuberculosis-like lesions caused by R. equi may
also occur in cattle and pigs, being the submandibular and other
lymph nodes the most frequent lesions present in these mammals
(Prescott, 1991; Bell et al., 1998; Gyles et al., 2012).
R. equi is a well-known opportunistic agent of infection in
patients co-infected with human immunodeficiency virus (HIV)
or organ transplanted patients (Harvey and Sunstrum, 1991;
Prescott, 1991; Topino et al., 2010; Savini et al., 2012). Similarly
to equine infections, human infections are usually located in the
lung, causing pneumonia and abscesses, with associated fever,
cough, and chest pain (McNeil and Brown, 1994; Topino et al.,
2010). However, the infection can disseminate and cause lesions
in other organs or bacteraemia becoming often fatal, both in
AIDS and non-AIDS immunosuppressed patients (Prescott, 1991;
McNeil and Brown, 1994; Topino et al., 2010). Even with an early
diagnostic and appropriate treatment, mortality rates in AIDS
patients can be high (Topino et al., 2010). Treatment of R. equi
infections can be difficult, requiring judicious choice of combina-
tion of antibiotics and prolonged therapy to avoid relapse (Topino
et al., 2010). Furthermore, antibiotics effective in vitro against R.
equi cells may not be effective in vivo. R. equi is susceptible to
several classes of antibiotics, such as macrolides, rifamycins, flu-
oroquinolones, aminoglycosides, glycopeptides, like vancomycin,
and imipenem. The bacterium shows a variable susceptibility to
cotrimoxazole, tetracycline, chloramphenicol, clindamycin, and
cephalosporins and it is commonly resistant to beta-lactams
with some acceptable susceptibility to imipenem (Prescott, 1991;
Weinstock and Brown, 2002). Strains of R. equi resistant to
ciprofloxacin, rifampin, and macrolide antibiotics have already
been reported (Giguère et al., 2010; Niwa and Lasker, 2010;
Riesenberg et al., 2014).
The tolerance and adaptation of Rhodococcus, specially R. ery-
thropolis, to several different and aggressive conditions, like the
presence of the toxic compounds toluene, carveol, and carvone
or heavy-metals and antibiotics (de Carvalho et al., 2005, 2007;
Hara et al., 2010; Riesenberg et al., 2014) has been related to the
high complexity and capacity of modification, under stress con-
ditions, of the fatty acid composition of the cell membrane, as
well as to the usage of putative intrinsic or acquired transport sys-
tems (de Carvalho et al., 2005; McLeod et al., 2006; Hara et al.,
2010). Since bacteria have the ability to use several mechanisms of
defense against hostile environments, it is important to know and
enlighten the mechanisms associated to the tolerance, adaptation
and resistance ofR. erythropolis. From the several adaptivemecha-
nisms displayed by bacteria, efflux systems have not, to the best of
our knowledge, been described in sufficient detail for rhodococci
(de Carvalho et al., 2009; de Carvalho, 2012).
TRANSPORT SYSTEMS PRESENT IN THE RHODOCOCCUS
GENUS
Membrane transport systems are present in both bacterial and
eukaryotic cells, participating in key cell functions such as the
uptake of essential nutrients, secretion of metabolites, extrusion
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Table 1 | Distribution of the families of transporter systems in the genomes of four distinct Rhodococcus species (Transporter classification
database, Saier et al., 2006; TransportDB, Ren et al., 2007).
Organism Genome Number of transporters Transporter type (%)
size (Mb) /Mb genome
ATP-dependent Ion channels PTS Secondary transporters Unclassified
R. equi 103S 5.043 0.09 54.9 3.4 n.i. 38.5 3.2
R. erythropolis PR4 6.896 0.10 55.7 2.2 1.0 39.4 1.7
R. opacus B4 8.835 0.09 47.1 2.1 0.8 48.1 1.9
R. jostii RHA1 9.703 0.08 46.5 2.1 0.7 48.6 2.1
ATP, adenosine triphosphate; PTS, phosphotransferase systems n.i., not identified.
of noxious byproducts, and maintenance of cellular homeosta-
sis by regulation of the intracellular concentrations of ions and
solutes (Saier, 2000). It is predicted that these systems constitute
3–16 % of the total number of open reading frames (ORFs) in
prokaryotic genomes (Ren and Paulsen, 2007). Overall, the sub-
strates of such transport systems are water-soluble molecules that
will not traverse the cell membrane by simple diffusion, includ-
ing metals, sugars, amino acids, peptides, oligosaccharides, and
macromolecules, such as proteins and nucleic acids (Saier, 2000).
Transporter systems are currently classified according to their
function and molecular phylogeny into seven classes, namely
Class 1, channels and pores; Class 2, electrochemical potential-
driven transporters (including secondary active transporters);
Class 3, primary active transporters; Class 4, group transloca-
tors; Class 5, transport electron carriers; Class 8, accessory factors
involved in transport; Class 9, incompletely characterized trans-
port systems (Saier, 2000; Saier et al., 2009).
The focus of this review is on the transporter systems of the
above classes that present the capability to extrude from the
rhodococcal cell toxic compounds including solvents, antibiotics
and biocides, which are generally designated as efflux pumps.
These efflux pumps can be specific, extruding one compound
or a class of compounds or multidrug resistance (MDR) efflux
pumps that extrude multiple classes of toxic compounds. These
MDR transporters can belong to the primary transporters super-
family adenosine triphosphate (ATP)-binding cassette (ABC) that
couples the hydrolysis of ATP to the substrate translocation
(Class 3) or to the secondary transporter families major facili-
tator superfamily (MFS), resistance-nodulation-division (RND)
superfamily, multidrug and toxic compound extrusion (MATE)
family and small multidrug resistance (SMR) that use the proton
motive force or the membrane sodium gradient (MATE trans-
porters only) to drive the extrusion of their substrates (Class 2)
(Paulsen et al., 1996).
In the current era of genomics, rhodococci have generated
some interest due to their wide biotechnological applications and
26 genome sequencing projects are currently ongoing, of which
five are already completed and represent four species: R. ery-
thropolis, R. equi, R. opacus, and R. jostii (National Center for
Biotechnology Information, 2005). The analysis of these genomes
revealed different structures, R. equi and R. erythropolis present
smaller circular genomes (5 and 6.9Mb) whereas R. opacus and R.
jostii have larger linear chromosomes (8.8 and 9.7Mb) (National
Center for Biotechnology Information, 2005; McLeod et al., 2006;
Letek et al., 2010; Pathak et al., 2013; Shevtsov et al., 2013).
Another characteristic of rhodococcal genomes is the common
presence of plasmids, one to five per strain, either circular or lin-
ear, that range in size from 3 kb to more than 1Mb, accounting
for up to 20% of the entire genome (e.g., R. jostii strain RHA1)
(Letek et al., 2008, 2010). Despite these differences, the ratio of
transporter systems per Mb of genome is similar in the sequenced
genomes (0.08–0.1), although some differences are encountered
when analyzing the overall number of transporters (Table 1).
An in silico comparative analysis predicted the occurrence of
MDR efflux pumps in the genomes of these rhodococci, ascribed
to several transporter families. Of relevance is the prediction of
the presence of structurally complex andmultipartite RND super-
family MDR efflux pumps in this gram positive genus. However,
a main constraint of this analysis is the lack of in vivo data sup-
porting the transporters classification, either in rhodococci or
in other related genera. A second constraint is the low identity
observed for the putative efflux pumps identified among the sev-
eral rhodococcal species, with identity values of 65–75% for the
majority of the transporters, with an exception for R. jostii RHA1
and R. opacus B4 that present high identities (up to 99%). These
low identity values are also registered when comparing puta-
tive efflux pumps from rhodococci and related genera, such as
Corynebacterium spp. andMycobacterium spp.
BLAST analysis of the putative MDR efflux pumps identi-
fied, which are mainly chromosomally-encoded, revealed a sim-
ilar number of transporters of the different families in the four
genomes analyzed, namely the occurrence of 11–15 ABC efflux
pumps, 50–70 MFS transporters, 5–9 pumps of the RND super-
family, 1–3 SMR efflux pumps and 1 MATE transporter. In
Table 2 are presented the MDR efflux pumps for which a high
identity (>75%) was found among the four rhodococcal species
in analysis.
The study of drug resistance efflux systems in the related genus
Mycobacterium is still in early stages, compared to other bacteria.
Nevertheless, some efflux pumps were described and experimen-
tal data gathered supporting their role in drug resistance (De
Rossi et al., 2006; Louw et al., 2009; Viveiros et al., 2012; Machado
et al., 2012). Genome analysis showed the presence of rhodococ-
cal transporters with significant identity to those efflux pumps
(Table 2). For example, the MFS efflux pump Rv1258c from
M. tuberculosis H37Rv, associated with the export of the antibi-
otics isoniazid, rifampicin, ethambutol, and ofloxacin (Louw
et al., 2009; Machado et al., 2012), has ca. 55% identity to the
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Table 2 | In silico prediction of chromosomal MDR transporter systems involved in resistance to antimicrobial agents in representative
rhodococcal species (sharing > 75% identity) and their relation to Mycobacterium tuberculosis H37Rv transporters.
Type of transporter Rhodococcal strain
R. equi 103S R. erythropolis PR4 R. jostii RHA1 R. opacus B4 M. tuberculosis H37Rv
PUTATIVE ABC TRANSPORTER INTEGRAL MEMBRANE SUBUNIT
REQ_11220 RER_56560(71%) RHA1_ro02603(69%) ROP_03190(77%) –
REQ_12170 RER_43530(84%) – – –
REQ_20440 RHA1_ro06840(83%) ROP_68250(83%) –
REQ_24790 RER_32730(77%) RHA1_ro00945(80%) ROP_06760(80%) Rv1686c (64%)
REQ_30790 RER_46100(75%) RHA1_ro02603(50%) –
RER_44380 RHA1_ro04792(88%) ROP_48830(88%) –
PUTATIVE ABC TRANSPORTER INTEGRAL MEMBRANE/ATPase SUBUNITS
REQ_03250 RER_03410(72%) RHA1_ro04169(79%) ROP_40980(79%) –
REQ_14720 RER_41210(74%) RHA1_ro06013(78%) ROP_60720(78%) Rv0194 (43%)
RHA1_ro01004 ROP_07300(97%) Rv1819c (52%)
PUTATIVE MFS TRANSPORTER
REQ_00410 RHA1_ro05096(75%) ROP_51570(77%) –
REQ_08920 RER_55050(75%) Rv1634 (53%)
REQ_09900 RER_46140(79%) RHA1_ro04995(78%) ROP_50560(80%) –
REQ_13270 RER_55220(78%) –
REQ_15920 RHA1_ro01594(76%) ROP_12980(77%) Rv1258c (55%)
REQ_18780 RHA1_ro06618(75%) ROP_66540(75%) EfpA (53%)
REQ_19100 RHA1_ro06636(83%) ROP_66710(83%) –
REQ_20430 RHA1_ro05369(80%) ROP_54620(80%) –
REQ_23090 RER_31910(75%) RHA1_ro00861(75%) ROP_05990(75%) –
REQ_27500 RER_35250(77%) RHA1_ro01063(78%) ROP_07910(77%) –
REQ_30590 RER_38560(80%) RHA1_ro01413(83%) ROP_11240(84%) Rv_2508c (51%)
REQ_36620 RER_17440(75%) RHA1_ro01949(76%) Rv_0783c (51%)
REQ_38480 RER_15430(79%) –
REQ_39850 RER_13960(85%) RHA1_ro05519(87%) ROP_55930(87%) –
REQ_45350 RHA1_ro04268(79%) ROP_41810(79%) –
RER_13470 RHA1_ro04142(79%) ROP_40760(79%) –
RER_19430 RHA1_ro05093(83%) ROP_51550(82%) Rv2459 (35%)
RER_39310 RHA1_ro02360(82%) ROP_20740(85%) –
RER_55700 RHA1_ro04268(78%) ROP_41810(78%) –
PUTATIVE SMR PROTEIN
REQ_07770 RER_09840(81%) RHA1_ro04738(80%) ROP_48320(80%) –
PUTATIVE MATE EFFLUX FAMILY PROTEIN
REQ_19210 RER_26360(74%) RHA1_ro06648(78%) ROP_66870(77%) Rv_2836c (63%)
PUTATIVE RND FAMILY PROTEIN
mmpL1 REQ_03240 RER_03400(78%) RHA1_ro04168(80%) ROP_40970(79%) –
mmpL2 REQ_22980 RER_31970(77%) RHA1_ro03267(79%) ROP_27830(80%) –
mmpL3 REQ_34640 RER_09760(74%) RHA1_ro11238(74%) ROP_00400(76%) MmpL11 (30%)
mmpL4 REQ_34730 RHA1_ro06222(73%) ROP_62810(73%) Rv0206c (40%)
mmpL6 REQ_44510 RER_52340(76%) RHA1_ro02326(78%) ROP_20440(77%) –
The identity percentage shown was calculated relatively to R. equi 103S or R. erythropolis PR4 genomes.
transporters REQ_15920, RHA1_ro01594, and ROP_12890 of R.
equi 103S, R. jostii RHA1, and R. opacus B4, respectively.
Putative MFS MDR transporters are also found in the
rhodococcal plasmids sequenced so far; two in the linear plasmid
pREL1 (272 kb) of R. erythropolis PR4, and several in the linear
plasmids of R. jostii RHA1, namely two in pRHL1 (330 kb), six in
pRHL2 (440 kb), and one in pRHL3 (1.1Mb).
Specific efflux pumps also occur in the rhodococci genomes,
with a substrate specificity mainly devoted to the transport of
heavy-metal ions, such as arsenite and cadmium, a clear reflection
of the environmental niches that these species inhabit (Table 3).
Another particular characteristic is their presence in rhodococ-
cal plasmids. A large number of these plasmids are conjugative
or mobilizable (Letek et al., 2010) carrying several niche-specific
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Table 3 | List of putative specific transporters for heavy-metals present in representative rhodococcal species.
Substrate Transporter Family Species
(No. of transporters)
Gene location
(No. of transporters)
Arsenite ArsA Arsenite-antimonite (ArsAB) R. equi (1) C
efflux family R. erythropolis (4) C (3) + P (1)
R. jostii (3) C
R. opacus (4) C
ArsB R. equi (1) C
R. erythropolis (1) C
R. jostii (1) C
R. opacus (1) C
UN Arsenical resistance-3 (ACR3) R. equi (1) C
family R. erythropolis (2) C (1)+ P (1)
R. jostii (1) C
R. opacus (3) C
Cadmium UN P-type ATPase R. jostii (1) C
Cobalt UN ATP-Binding cassette (ABC) R. equi (8) C
R. erythropolis (6) C
R. jostii (5) C
R. opacus (5) C
Cobalt/Zinc/Cadmium UN P-type ATPase R. equi (4) C
R. erythropolis (5) C (3) + P (2)
R. jostii (5) C
R. opacus (3) C
UN, unnamed; C, chromosome; P, plasmid.
genes, including the pathogenicity island PAI, which harbors the
vap genes, such as vapA that encodes a surface antigen in R. equi
(Takai et al., 2000). Plasmid-mediated resistance to heavy-metals
was first reported in a strain of R. erythropolis. The plasmids
identified carried determinants conveying resistance to arsenate,
arsenite, and cadmium (Dabbs and Sole, 1988). In the same year,
plasmid-borne cadmium resistance was also described for the
phytopathogenic R. fascians (Desomer et al., 1988). In both stud-
ies, co-localization of a determinant encoding resistance to the
antibiotic chloramphenicol was also observed in some plasmids
(Dabbs and Sole, 1988; Desomer et al., 1988). Following studies
on the 160 kb conjugative plasmid pRF2 of R. fascians revealed the
chloramphenicol-resistance determinant cmr as coding for a MFS
transporter with 12 transmembrane segments (Desomer et al.,
1992). A cmr-like gene, cmrA, encoding the CmrA protein with
86% amino acid identity to Cmr, was also found on a plasmid
of R. rhodochrous (Quan and Dabbs, 1993; De Mot et al., 1997). A
putative tetracycline specificMFS efflux pump, RHA1_ro08008, is
also found in the R. jostii RHA1 linear plasmid pRHL1 (1.1Mb).
BLAST analysis of this putative Tet pump revealed homology
(86% identity) to a MFS transporter in R. opacus B4 chromosome
(ROP_04480).
Determinants for resistance to heavy-metals are widely dis-
seminated in rhodococcal plasmids (Table 3). For instance, the
linear plasmid pREL1 from R. erythropolis PR4 harbors several
heavy-metal transporters, including predicted cadmium-efflux P-
type ATPases, a cadmium transporter from the cadD family and
an arsenite transporter from the ACR3 family (Sekine et al., 2006).
The characterization of the catabolic plasmids pRHL3 from R.
jostii RHA1 and pDB2 from R. erythropolis BD2 (210 kb) showed
the presence of several transporters involved in the export of
the metal ions arsenate, arsenite, cadmium, copper and mer-
cury (Dabrock et al., 1994; Stecker et al., 2003; Warren et al.,
2004). Heavy-metal transporters can also occur in the chromo-
some and many are substrate promiscuous transporting many
different classes of compounds.
TRANSPORT OF SOLVENTS, ANTIBIOTICS, AND BIOCIDES
As mentioned before, rhodococci are well known for thriving
under harsh environments, where few other microorganisms are
able to endure. Such behavior has been mostly related to changes
in the cell wall, that hinders the diffusion of deleterious com-
pounds; or to the metabolic versatility displayed by members of
this genus, which result in the partial or total mineralization of the
toxic compounds or proper processing for use as carbon and/or
energy source (Larkin et al., 2005; de Carvalho et al., 2005, 2009;
de Carvalho, 2012). Although active transport is a well-known
tool for microbial strains to deal with toxic compounds (Torres
et al., 2011; Kriszt et al., 2012; Nikaido and Pagès, 2012; Segura
et al., 2012) there are very few works where this method has
been clearly identified in Rhodococcus strains despite this possi-
bility is often suggested. Such exceptions include: (a) the selec-
tive transport of n-hexadecane by R. erythropolis S+14He (Kim
et al., 2002). This particular strain was shown to discriminate
n-hexadecane from mixtures of alike molecules and transport it
into the cell by an energy driven mechanism, where it could be
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accumulated and used as carbon source; (b) the uptake of cesium
ion through an energy dependent mechanism, which configures
its application in the treatment of cesium contaminated envi-
ronments (Ivshina et al., 2002); (c) the uptake of phthalates by
R. jostii RHA1, where, unlike in the two former examples, the
active influx behavior was specifically ascribed to an ABC trans-
porter, encoded by patDABC genes. From bioinformatic analysis
with the NCBI Conserved Domains database, the authors were
able to suggest the individual roles of the components within the
transporter. Thus, PatA was the cytoplasmic ATP-binding compo-
nent of the transporter, PatB and PatC were membrane-spanning
permease components of the transporter and PatD was the extra-
cytoplasmic substrate-binding component of the transporter. The
work performed moreover contributed to establish the feasibility
of the use of R. jostii RHA1 cells as scavengers of the envi-
ronmentally pollutant phthalates (Hara et al., 2010). The active
transport of 4, 6-dimethyldibenzothiophene (DBT) in R. erythro-
polis LSSE8-1 was highly promoted after effective transformation
of the wild type strain with the plasmid HcuABC containing the
DBT uptake genes of Pseudomonas delafieldii R-8 (Wang et al.,
2011). This enhanced the transfer of DBT into the cells, resulting
in higher desulfurization rates when compared to the wild-type
R. erythropolis LSSE8-1.
Similarly to M. tuberculosis, the mycolic acids of Rhodococcus
sp. should contribute to a high hydrophobicity of the cell enve-
lope thus hampering the entry of antibiotics to the cell. A
relation between antibiotic resistance and lipid composition of
rhodococci grown on n-alkanes was found in strains of R. ruber
(Kuyukina et al., 2000). After growth in rich organic media con-
taining gaseous or liquid n-alkanes, the cells exhibited increased
resistance to aminoglycosides, lincosamides, macrolides, and β-
lactams. The challenged R. ruber cells increased their lipid con-
tent and the percentage of saturated straight-chain fatty acids,
while starting to produce cardiolipin and phosphatidylglycerol.
The resulting decrease in the permeability of the cell envelope
should have been responsible for a decreased penetration of the
antibiotics in the cells.
Actinomycetales include species which producemost of antibi-
otics in use as secondary metabolites (Fiedler et al., 2005; McLeod
et al., 2006; Waksman et al., 2010). Biosynthesis of antibiotics
has been reported for Rhodococcus spp. (Kitagawa and Tamura,
2008). It is thus expected that these cells produce transporters
involved in drug export. During a partial genome sequencing
of R. equi ATCC 33701, no beta-lactamase enzymes or amino-
glycoside acetyl transferase genes were identified, but poten-
tial drug-efflux systems included 12 efflux protein genes and
at least 25 ABC transporter proteins (Rahman et al., 2003).
However, the more recent genome analysis of R. equi 103S
revealed the presence of a wide array of antibiotic resistance deter-
minants, including five aminoglycoside phosphotransferases and
10 beta-lactamases (Letek et al., 2010). Rhodococcus sp. RHA1
contains genes encoding a high number of peptide synthetases
and polyketide synthases (providing evidence for an extensive
secondary metabolism) and a corresponding high number of
transporters potentially involved in drug export (McLeod et al.,
2006). Resistance to glycopeptides has been reported in R. equi
human clinical strains (Hsueh et al., 1998) and a novel operon
for glycopeptide resistance, vanO, with low homology with ente-
rococcal operons, was recently identified in R. equi isolated from
soil (Gudeta et al., 2014).
As mentioned previously, two efflux exporters of chloram-
phenicol have been identified in the strains R. fascians and R.
rhodochrous. Also, two putative tetracycline transporters are also
present in the R. jostii and R. opacus genomes. In general, the
majority of the MDR efflux pumps present in other bacteria, such
as Escherichia coli and Staphylococcus aureus have the capacity to
extrude antibiotics as well as other antimicrobial agents known as
biocides (Poole, 2005). Thus, it is possible that the putative MDR
efflux pumps present in the several rhodococcal species also share
the same capacity of biocide extrusion.
INHIBITION OF TRANSPORT IN THE RHODOCOCCUS GENUS
Targeting the membrane transport systems is an attractive option
to reduce the activity of efflux pumps when retention of a given
substrate is desired either because (i) it guarantees more substrate
for a biotransformation occurring inside the cell or (ii) it pro-
motes accumulation of a toxic compound inside the cell, allowing
it to reach the intended target, as in the case of antibiotics that
are subject to efflux by Rhodococcus species. The discovery and
development of inhibitory molecules and strategies to circumvent
efflux are needed. Inhibitors of efflux pumps have been identified
through standard high-throughput screening of synthetic chem-
ical libraries of compounds or have been isolated from natural
sources known for their ethnomedicinal properties (Pagés et al.,
2011; Rodrigues et al., 2011). More recently, molecular model-
ing combined with crystallography and docking-studies allowed
the directed drug design of the best pharmacophoric groups of
putative inhibitory molecules that might be involved in substrate
recognition and binding within a specific efflux pump, as was the
case of spectinamides in M. tuberculosis. A new group of anti-
tubercular compounds was created modifying a molecule, spec-
tamycin, to prevent efflux by the Rv1258c pump ofM. tuberculosis
(Lee et al., 2014), the one that has a high identity to transporters
present in the genome of different rhodococci. Consequently, the
development of antimicrobial agents that are less susceptible to
be effluxed or which may interfere with the kinetics of transport,
will be a great benefit to revive or reuse many of the drugs that
have become ineffective as antimicrobials and can also be of great
advantage for biotransformation purposes for genus of the order
Actinomycelales (Fernandes et al., 2003; Rodrigues et al., 2011;
Torres et al., 2011).
The development of new tools and methodologies that afford
the intelligent design of compounds that target distinct proper-
ties of a given efflux pump and allow the study of the kinetics
of transport is deeply needed. One of the recent developments
in this area has been the development of methodologies based
on the in vivo real-time fluorometric detection of the accumu-
lation and efflux kinetics of fluorescent dyes such as ethidium
bromide (Viveiros et al., 2008, 2010), red-Nile (Bohnert et al.,
2010), or bisbenzimide (Hoechst 33342) (Coldham et al., 2010).
Such methodologies were very helpful for the study of the efflux
activity in different mycobacterial species (Viveiros et al., 2008,
2010; Machado et al., 2012). The genomic and physiological sim-
ilarities between Mycobacterium and Rhodococcus genus makes
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FIGURE 1 | The temporal [(A) 5min, (B) 30min, (C) 60min] effect of the efflux inhibitor verapamil used at a non-lethal concentration on the membrane
potential of R. erythropolis cells stained by a commercial dye. Orange/red cells—fully polarized. Green cells—fully depolarized. Adapted from Vencá (2012).
this research approach suitable for studies aiming to identify
promising targets for effective compounds to control efflux in
the Rhodococcus genus. Recently, and following this rational, the
detection of efflux activity in R. erythropolis DCL14 cells, in
particular the real-time fluorometric detection of accumulation
and efflux of ethidium bromide, a common substrate of MDR
efflux pumps, has provided preliminary evidences of efflux activ-
ity in this species (Vencá, 2012). Moreover, it has also been
shown that this efflux activity can be inhibited by compounds
known as inhibitors of efflux pumps in other bacteria, namely
Mycobacterium spp. (Viveiros et al., 2012), S. aureus (Costa et al.,
2011) and E. coli (Viveiros et al., 2007; Paixão et al., 2009), such
as the protonophore carbonyl cyanide m-chlorophenylhydrazone
(CCCP) or the calcium channel blockers verapamil and the
phenothiazines thioridazine and chlorpromazine (Vencá, 2012).
These compounds are known to interfere with the membrane
potential of eukaryotic and prokaryotic cells by disrupting or
reducing the membrane potential therefore depleting the energy
necessary to maintain active transport (Amaral et al., 2007;
Viveiros et al., 2008; Rodrigues et al., 2011). An illustrative exam-
ple of the disruption ofR. erythropolismembrane potential during
60min of exposure to a non-lethal concentration of verapamil can
be seen in Figure 1.
To be classified as an efflux inhibitor, a compound has to sat-
isfy some basic criteria (Lomovskaya and Watkins, 2001): (i) it
must enhance the activity of multiple substrates of the pump by
retaining them inside the cells; (ii) it should have no activity in
strains that do not have the efflux pump; (iii) it should increase
accumulation and decrease efflux of the efflux pump substrates;
(iv) its activity must not affect directly the integrity of the bac-
terial membrane nor the cell viability, at the concentrations used
for efflux inhibition. CCCP is the canonical example of an efflux-
inhibitor that uncouples the proton gradient established during
the normal activity of electron carriers in the electron transport
chain, seriously affecting the energy level of the membrane, caus-
ing a dissipation of the proton motive force, with a similar effect
as the one seen in Figure 1, therefore affecting all the transporters
that depend on this energy source to operate (Kašèáková et al.,
2012). The same effect can be indirectly achieved by the use of
ATPase inhibitors such as sodium orthovanadate, described as an
inhibitor of efflux systems dependent on ATPases, like the ABC
efflux pumps (Komeda et al., 1997; Garvey and Piddock, 2008;
Vencá, 2012).
These powerful, direct or indirect, uncouplers of the proton
motive force promote the collapse of the membrane energy and
consequently, when used at low concentrations that do not affect
the viability of the cell, they inhibit the active transport through
the bacterial membrane of efflux substrates such as excretion
metabolites, toxic compounds, solvents, biocides, and antibi-
otics. The inhibitory activity results in the accumulation of the
substrate inside the bacterial cell promoting their intracellular
activity, either inhibiting the bacterial replication (as in the case
of antibiotics and antibiotic resistance) or promoting intracel-
lular biotransformations (as in the case of organic compounds
transformation/degradation and solvent tolerance). Controlling
this transport phenomenon has important implications on ther-
apeutics and biotransformation as it has been demonstrated by
different groups on the closely related Mycobacterium genus that
we have previously demonstrated the Rhodococci share great
affinities (Fernandes et al., 2003; Torres et al., 2011; Viveiros et al.,
2012).
From the results obtained so far by different groups, either on
the physiological level or the genotypic level, it is evident that
rhodococci have the ability to easily gain tolerance to solvents
and antimicrobial drugs and the inhibition of their efflux systems
may be an effective strategy to improve both the biotechnolog-
ical and bioremediation properties of these bacteria and also to
improve the antimicrobial effectiveness of the few antibiotics that
are active against these bacteria. By blocking efflux pumps activ-
ity, deleting the efflux pump or controlling the regulatory factors
(e.g., sigma factors) that control the efflux pump expression the
concentration of the transported substrate retained inside the
cells will be higher and its effect may increase (Fernandes et al.,
2003; Kita et al., 2009; Segura et al., 2012; Vencá, 2012). This
approach leads to the possibility to reduce not only the intrin-
sic resistance/tolerance but also to reverse the acquired resis-
tance/tolerance of bacteria to drugs and solvents (Fernandes et al.,
2003; Viveiros et al., 2008, 2012; Rodrigues et al., 2011). Nothing
has been found in the literature about the usage of rhodococci
efflux pump knock-out mutants for biotechnological purposes.
Noteworthy to mention, reversing tolerance to solvents may not
be the desirable biotechnological outcome when bacteria, such
as rhodococci, are used for bioremediation purposes: inhibiting
efflux pumps in the presence of a toxic pollutant may compromise
bacterial viability.What is intended is to optimize the biodegrada-
tive characteristics of the bacteria without affecting its viability
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and to promote the most beneficial aspects of their bioremedi-
ation abilities which could contribute to the bioremediation of
contaminated sites (Fernandes et al., 2003; de Carvalho et al.,
2007; de Carvalho, 2012).
The presence of efflux activity and active efflux pumps in
rhodococcal cells together with the several catabolic pathways dis-
played by Rhodococcus spp. clearly suggest an important role of
efflux systems in the adaptation of these bacteria to their eco-
logical niches. For example, drug resistance efflux pumps may be
crucial to the survival of Rhodococcus that are present in the soil,
sharing their habitat with several antibiotic producing bacteria,
such as Streptomyces spp. It should, nevertheless, be pointed out
that Rhodococcus cells are able to produce large numbers of sec-
ondary metabolites and of degrading/converting a wide variety
of substrates of substrates. For such compounds to be degraded
and/or converted they must be allowed to enter the cell and
reach the necessary enzymes. The complex system regulating the
entrance/exit of compounds that are able to kill many other bac-
teria is still far from being elucidated and interfering with efflux
is obviously one strategy to control the highly adaptative traits of
the Rhodococcus genus (de Carvalho and da Fonseca, 2005b; de
Carvalho, 2012).
CONCLUSION AND PERSPECTIVES
From the evidences gathered in this review it is possible to con-
clude that the Rhodococcus genus is composed by highly adaptable
bacteria capable of tolerating high amounts of a wide range of
toxic compounds and it has, therefore, interesting applications in
biotechnology and bioremediation. The tolerance of rhodococci
is clearly associated with its plastic genome coding for numer-
ous efflux pumps, combined with a very versatile metabolism that
makes this genus unique in terms of the ability to survive under
extreme environmental conditions. This review brings additional
insights on the distribution among rhodococcal species of genes
involved in active transport and mobilization previously demon-
strated and reported in the literature. It is clear that rhodococci
specialized in transporting substrates such as solvents and drugs,
with some rhodococcal species, such as R. opacus, R. erythropo-
lis, and R. jostii, being well equipped with genes for the transport
of many different substrates. This reviews represents a starting
point for the development of further studies connecting the cat-
alog of rhodococcal genes involved in active transport, that are
currently being unraveled by whole-genome sequencing projects,
with their respective panel of substrates and inhibitors, transport
kinetics and possibility to control the kinetics for biotechnological
purposes.
In the genomic era, the most common methodology to study
transporter proteins is still to sequence the bacteria genome and,
by comparison of homologous bacterial genomes and the strategy
of knocking-out or overexpressing the genes, to find sequences
that would probably encode efflux pumps. This approach is fur-
ther supplemented with the determination and comparison of
the inhibitory effects of different substrates against the wild-type
and knock-out/overexpressing variants and deducting from the
reduction of the susceptibilities to these substrates, a direct con-
nection between the efflux pump and the substrate effluxed. This
methodology is not adequate to study substrate transport from a
bioengineering perspective and does not allow the determination
of transport parameters. Therefore, it is necessary to continue
the development of adequate methods to characterize and under-
stand transport phenomena in bacteria, e.g., by detection and
quantification of drug and solvent transport across the bacterial
cell wall. This would greatly improve the biotechnological and
bioremediation applications of this genus. The determination of
kinetics and transport parameters should be further explored and
these models and parameters will be of great importance to con-
trol the bacterial transport machinery in order to optimize their
beneficial aspects. From the biomedical point of view, the abil-
ity to retain and concentrate antimicrobials inside Rhodococcus
cells by the use of inhibitors or chemical modifications of sub-
strates to circumvent efflux and reduce tolerance/resistance, will
undoubtedly benefit the therapeutics of rhodococcal infections as
it is now recognized for mycobacterial infections (Adams et al.,
2014; Viveiros and Pieroni, 2014).
The association of efflux activity and adapted/tolerant/
resistant phenotypes in the Rhodococcus genus, either for biotech-
nological or biomedical purposes, is nowadays a challenge for
science. The functional identification and characterization of
the key genes involved in both solvent and antibiotic trans-
port, including those participating in regulatory mechanisms, the
creation of knock-out gene mutants for these transport mech-
anism and the design and/or the identification of new drugs
that can overcome efflux in the genus, will be one of the major
challenges in this field for the coming future. The sum-up of
results gathered in the literature so far clearly indicate that this
group of bacteria possesses enough genetic information to deploy
a series of physiological strategies to respond to the presence
of noxious compounds in the surrounding environment and
is able to use a series of transport mechanisms to survive to
these external menaces. It is now up to us to learn how to
master such mechanisms in order to promote the biodegrada-
tion potential and reduce the pathogenicity of the Rhodococcus
genus.
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